Analgesics, also known as painkillers, are used to treat and reduce pain in the body. Typically, they are used when the pain is severe and becomes unbearable for the patient. Non-opioids, opioids, and compound analgesics (a combination of both opioids and non-opioids) are the major analgesic products used globally. The emergence of analgesics is mainly attributed to the increase in acute and chronic diseases, as well as the rising incidence of cancer worldwide.
Opioid drugs are the strongest types of analgesics, which are derived from opium. They are chiefly used for the treatment of moderate to severe pain and are mostly available through prescription. On the other hand, non-opioid drugs are not derived from opium but include acetaminophen. They also include non-steroidal anti-inflammatory drugs (NSAIDs) and are majorly used for the treatment of mild to moderate pain. In addition, non-opioid drugs are sometimes used alongside stronger painkillers. They are mostly available over-the-counter (OTC); however, some NSAIDs, such as Celebrex, Cataflam, and Motrin, are available through prescription only.
The world analgesics market is expected to achieve moderate growth in the near future, majorly because of factors such as increase in cardiovascular disease, cancer, and arthritis and growing geriatric population. Recurring pain and aches experienced by the ageing population is another factor the helps the market growth. In addition, increasing investments in R&D by the public and private sector, with key emphasis on the classes of compounds for formulating new therapeutics, are further expected to drive the market. However, factors such as uncontrolled prescription of opioids, drug abuse, and unregulated government policies are likely to restrain the growth of the market.
The report segments the analgesics market on the basis of type, route of administration, and geography. On the basis of type, the market is segmented into non-opioids and opioids. According to the route of administration, it is segmented into oral, intravenous, rectal, transdermal, and topical. Based on the geography, it is categorized into North America, Europe, Asia-Pacific, andLAMEA.
Companies adopt acquisition as their key development strategy in the analgesic market. A comprehensive competitive analysis and profiles of major market players, such as Bayer AG, Novartis AG, GlaxoSmithKline PLC, Pfizer Inc., Johnson & Johnson, Reckitt Benckiser (RB), Endo Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, and Sanofi, are provided in this report.
KEY BENEFITS FOR STAKEHOLDERS:
ANALGESICS MARKET KEY SEGMENTS:
SIMILAR MARKET STUDIES
Summary Our new report, Asia-Pacific Gastrointestinal (GI) Stenting Procedures Outlook to 2020, provides key market data on the Asia-Pacific Gastrointestinal (GI) Stenting Procedures. The report provides procedure volumes within market segments GI Stenting Procedures using Fully Covered Gastrointestinal Stents, GI Stenting Procedures using Partially Covered Gastrointestinal Stents and GI Stenting Procedures ...
July 2014 | $1500 | View Details >>
PharmaPoint: Type 1 Diabetes Global Drug Forecast and Market Analysis to 2023 Summary Type 1 diabetes (T1D) is an autoimmune disease that permanently destroys beta cells of the pancreatic islet, which means that the body can no longer produce insulin. Over the last 90 years, insulin therapy has been evolving continuously, as ...
March 2015 | $10995 | View Details >>
Sicca Syndrome (Sjogren) - Pipeline Review, H2 2015 Summary Global Markets Directs, Sicca Syndrome (Sjogren) - Pipeline Review, H2 2015, provides an overview of the Sicca Syndrome (Sjogren) s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sicca Syndrome (Sjogren) , complete with comparative analysis at various stages, therapeutics ...
December 2015 | $2000 | View Details >>
According to Stratistics MRC, the Farm Animal Diagnostics market accounted for $2,570 million in 2015 and is expected to reach $4,215 million by 2022 growing at a CAGR of 7.3% from 2015 to 2022. The up surging zoonotic and food borne diseases, rise in the number of farms driven by ...
June 2016 | $4150 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research